CommercialCoverageMedium impact
Total Ankle Replacement
Blue Cross & Blue Shield of Mississippi·MS · Orthopedics, Podiatry·Medical Policy
We identified it
Jun 20, 2026
Summary
This is a comprehensive policy outlining when total ankle replacement is considered medically necessary versus investigational. The policy specifies that total ankle replacement using FDA-approved devices is medically necessary only for skeletally mature patients with moderate to severe ankle pain who meet specific criteria including arthritis in adjacent joints, severe contralateral ankle arthritis, ankle fusion on opposite side, or inflammatory arthritis.
Action Required
Immediately: Billing team must verify that total ankle replacement claims (CPT 27702) include documentation of patient meeting specific medical necessity criteria: skeletally mature with moderate to severe ankle pain limiting daily activity AND one of the following: arthritis in adjacent joints, severe contralateral ankle arthritis, contralateral ankle fusion, or inflammatory arthritis. Update prior authorization requests to include patient selection criteria and contraindications checklist. Claims not meeting these criteria will be denied as investigational.